Please use this identifier to cite or link to this item: doi:10.22028/D291-28182
Volltext verfügbar? / Dokumentlieferung
Title: Hepatic interleukin-6 production is maintained during endotoxin tolerance and facilitates lipid accumulation
Author(s): Dembek, Anna
Laggai, Stephan
Kessler, Sonja M.
Czepukojc, Beate
Simon, Yvette
Kiemer, Alexandra
Hoppstädter, Jessica
Language: English
Title: Immunobiology
Volume: 222
Issue: 6
Startpage: 786
Endpage: 796
Publisher/Platform: Elsevier
Year of Publication: 2017
Publikation type: Journal Article
Abstract: Gut-derived bacterial endotoxins, such as lipopolysaccharide (LPS), contribute to the pathogenesis of steatosis and steatohepatitis by activating Kupffer cells, the resident liver macrophages. Exposure of macrophages to low doses of LPS causes hyporesponsiveness upon subsequent endotoxin challenge, a phenomenon termed endotoxin or LPS tolerance. In the present study, we aimed to examine whether LPS-induced lipid accumulation is affected by endotoxin tolerance. LPS pretreatment reduced the expression of proinflammatory mediators upon subsequent high-dose LPS treatment in murine livers. Total lipid and lipid class analysis indicated that LPS-induced lipid accumulation was not affected by endotoxin tolerance, although it was dependent on the presence of Kupffer cells. Analysis of the expression of lipogenic genes revealed that sterol regulatory element binding transcription factor 1 (Srebf1) and its target ELOVL fatty acid elongase 6 (Elovl6) were upregulated upon LPS administration in livers from LPS-tolerant and non-tolerant mice, whereas the expression of peroxisome proliferator activated receptor-α (Ppara), a key inducer of lipid degradation, was decreased. Neither Interleukin (IL)-6 expression nor the activation of its downstream effector signal transducer and activator of transcription (STAT) 3 were suppressed in liver tissues of LPS-tolerized mice. In vitro experiments confirmed that recombinant or macrophage-derived IL-6 was a potent activator of the lipogenic factor STAT3 in hepatocytes. Accordingly, IL-6 treatment led to increased lipid levels in this cell type. In summary, our data show that endotoxin tolerance does not influence LPS-induced hepatic lipid accumulation and suggest that IL-6 drives hepatic lipid storage.
DOI of the first publication: 10.1016/j.imbio.2017.01.003
Link to this record: hdl:20.500.11880/27488
http://dx.doi.org/10.22028/D291-28182
ISSN: 1878-3279
Date of registration: 13-Jul-2019
Faculty: NT - Naturwissenschaftlich- Technische Fakultät
Department: NT - Pharmazie
Professorship: NT - Prof. Dr. Alexandra K. Kiemer
Collections:UniBib – Die Universitätsbibliographie

Files for this record:
There are no files associated with this item.


Items in SciDok are protected by copyright, with all rights reserved, unless otherwise indicated.